How useful is thrombocytosis in predicting an underlying cancer in primary care? a systematic review | Zendy

Sarah Bailey | Zendy; Obioha C. Ukoumunne | Zendy; Elizabeth A Shephard | Zendy; William Hamilton | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

How useful is thrombocytosis in predicting an underlying cancer in primary care? a systematic review

Author(s) -

Sarah Bailey,

Obioha C. Ukoumunne,

Elizabeth A Shephard,

William Hamilton

Publication year - 2016

Publication title -

family practice

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.955

H-Index - 100

eISSN - 1460-2229

pISSN - 0263-2136

DOI - 10.1093/fampra/cmw100

Subject(s) - medicine , thrombocytosis , primary care , cancer , intensive care medicine , medline , oncology , family medicine , platelet , political science , law

Although the association between raised platelet count (thrombocytosis) and cancer has been reported in primary and secondary care studies, UK GPs are unaware of it, and it is insufficiently evidenced for laboratories to identify and warn of it. This systematic review aimed to identify and collate evidence from studies that have investigated thrombocytosis as an early marker of cancer in primary care.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research